SUMMARY Fourteen studies of gastric acid secretion in a basal hour and in the two hours after a single intravenous injection of soluble insulin (0.01 to 0.40 units/kg) were performed in a healthy man. The peak acid output after insulin (measured as the two consecutive 15-minute samples giving the highest acid output) was significantly correlated with the lowest concentration of blood glucose, the fall in blood glucose, the rate of fall of blood glucose, and the maximum fall of blood glucose in any 15 minutes. Peak acid outputs after insulin were similar over the range 0.1 to 0.2 units/kg, and greater than at lower or higher doses.
Dose response relationships of insulin hypoglycaemia and gastric acid in man (Boots, insulin BP) was given as a rapid single intravenous injection over the range 0.01-040 units/kg body weight, and eight more 15-minute collections were made. The volume, pH, and titratable acidity of each specimen of gastric juice were measured by methods already described (Baron, 1963) . Venous blood was taken before the insulin injection, and 15, 30, 45, 60, 90 , and 120 minutes after the insulin to determine the whole blood glucose by a glucose oxidase AutoAnalyzer technique (Wincey and Marks, 1961) . Although capillary blood glucose may more closely resemble the glucose concentration reaching the glycoreceptors in the brain responsible for vagal stimulation, venous blood was collected in these studies, so that potassium, cortisol, and growth hormone could be measured as well. These results will be reported separately. Gillespie, Gillespie, and Kay (1969) found no significant difference between arterial and venous blood sugar concentrations during insulin tests.
There were 14 tests with insulin in the range 0.01-04 u/kg (Table I ). In the one test in which 0.01 u/kg insulin was given, gastric acid was not stimulated at all. The analyses of the relationships between acid secretion and blood glucose changes are based on 13 tests.
Results
In order to make maximum use of the data and to compare the results with the many variables which have been described, extensive analyses have been carried out to examine the relationships between acid secretion and changes in the concentration of blood glucose.
The following variables of acid secretion have Table I Timing of peak acid output in relation to insulin dose and changes in blood glucose been examined: (1) The basal acid output, calculated as the sum of the four basal 15-minute periods. (2) The peak acid output calculated as the sum of the two highest consecutive 15-minute collections, multiplied by two, and expressed as m-equiv/hour (Baron, 1962 and . (3) The maximum acidity, which was the highest concentration of titratable acidity achieved, expressed as m-equiv/litre. (4) The maximum increase in acidity being the maximum acidity minus the mean acidity in the half hour before insulin, and expressed as m-equiv/litre. Four variables of blood glucose were also examined. These were: (1) the lowest blood glucose, being the lowest value observed after the injection of insulin, and expressed as mg/100 ml.
(2) The maximum fall of blood glucose, being the difference between the initial blood glucose and the lowest blood glucose (expressed as mg/100 ml). (3) The rate of maximum fall of blood glucose, being the quotient of maximum fall of blood glucose divided by the time (in minutes) for blood glucose to fall from an initial value to its lowest concentration (expressed as mg/100ml per minute). (4) The maximum fall of blood glucose in any 15-minute period expressed as mg/100 ml.
Each of these four absolute values of blood glucose has also been expressed as a percentage of the initial, fasting blood glucose, thus giving eight different methods of expressing change in blood glucose.
BASAL SECRETION
There was no significant correlation between basal acid output and the blood glucose at the end of the basal hour (r = 0.02, p = 0.47).
SECRETION AFTER INSULIN
In the first half hour there was a slight and insignificant decrease in acid output. After this initial half hour of nearly constant secretion, volume, titratable acidity, and acid output increased to a peak and then declined to basal levels within two hours of the injection of the insulin. In one test, which was prolonged, acid output remained low in the third hour, and there was no suggestion of a late response after 120 minutes (Fig. 1) . Concentrations of blood glucose decreased to their lowest level at 30 minutes after the insulin injection and rose again towards basal levels within 2 hours. In only two tests was the lowest blood glucose delayed until 45 minutes.
TIMING OF PEAK ACID OUTPUT AND DOSE RELATIONSHIP
The peak half hour of acid secretion in the two hours after insulin was evenly distributed during the period 30-120 minutes, and showed no relationship to the dose of insulin, the lowest blood glucose, or the maximum fall in blood glucose Table I ). The usual hypoglycaemic symptoms and signs appeared 20-30 minutes after insulin was injected but lessened with repeated testing.
PEAK ACID OUTPUT
The graph of the relationship of peak acid output after insulin and the lowest blood glucose suggested that acid output increased as blood glucose levels became lower; the slope of the straight line fitted to this data was significantly different from zero (Fig. 2a) . However, further inspection of the data shown in Fig. 2a suggested that there might be a systematic biphasic acid secretory response to changes in the lowest blood glucose, with peak acid output rising as blood glucose falls, but declining when lowest blood glucose falls below about 15 mg/100 ml.
Some evidence for these trends was provided by fitting quadratics to the data ( Fig. 2b) : the residual variation of the data about the quadratics was significantly less than that about the straight line. Although the quadratic is the most convenient curve for testing whether a trend is linear, many other alternative curves would fit the data as well IRS or even better. For example, straight lines can be fitted separately for the two phases of the data, stimulation and inhibition, and these lines fit the data very well (Fig. 3) . There is no statistical basis for choosing between these various ways of describing the data, and the choice must rest on the plausibility of the relationships and their descriptive usefulness. With a small number of observations there is a good case forjust reporting the actual data and this policy has been adopted with the rest of the results of acid output.
With increase in the maximum fall of blood glucose (the second of the four variables of blood glucose examined), peak acid output after insulin increased, but again there was a situation in which large falls in blood glucose led to inhibition of acid output (Fig. 4a) . The graphs for the rate of maximum fall of blood glucose (third variable) (Fig. 4b) , and maximum fall of blood glucose in any 15 minutes (fourth variable) (Fig. 4c) showed similar trends. In all but one of the eight measurements of changes in blood glucose, a quadratic curve provided a better fit to the data than a straight line, thus providing evidence that the trends were not linear; however, it is also clear from the graphs that many of these measurements are highly correlated with each other.
TITRATABLE ACIDITY
The maximum acidity and increase in acidity were related in a very similar fashion to that of peak acid output to measurements of blood glucose.
INSULIN DOSE AND BLOOD GLUCOSE
There were of course statistically significant correlations (Table II) between the dose of insulin and all the different expressions of changes in blood glucose described above. The larger doses of insulin prolonged the hypoglycaemia so that two hours after the injection of insulin blood glucose was also inversely correlated with the dose of insulin.
INSULIN DOSE AND ACID OUTPUT
Peak acid outputs after insulin increased over the range 0.01-01 units/kg, were similar over the range 0d1-0.2 units/kg, and then tended to fall (Fig. 5a ). The relationship with insulin dose and acid output over the whole two hours was similar (Fig. 5b) These results are not compatible with the accepted assumption (Bachrach, 1953) that gastric acid secretion after intravenous insulin is an 'all-ornone' response to a blood sugar below 50 mg/100 ml, and suggest instead a relationship between insulin dose, hypoglycaemia, and acid secretion by the stomach. The hypoglycaemia-sensitive cephalic centres (J6gi, Strom, and Uvnas, 1949) may respond to the lowest blood glucose concentration achieved, the absolute fall, the maximum rate of fall, or the maximum fall in any unit time. The hypoglycaemic stimulus might be either an absolute change in blood glucose concentration or a proportion of initial concentration of blood glucose before the stimulus. Inhibition may occur in association with extreme hypoglycaemia. The present data are compatible with all these possibilities. There are three major phenomena to be considered and they will be discussed separately.
AN HYPOGLYCAEMIC THRESHOLD FOR THE INITIATION OF ACID STIMULATION
The smallest dose of insulin (0-03 u/kg), which elicited an acid response from the subject produced a blood glucose as low as 36 mg/ml. An even smaller dose (0.01 u/kg) produced a blood glucose of 58 mg/100 ml but no acid stimulation. It was not possible from these limited studies to determine a precise hypoglycaemic threshold for initiation of acid secretion, but various estimates have been made ranging from 18-67 mg/100 ml blood sugar (Stempien, Lee, and Dagradi, 1968) to 50-85 mg/100 ml blood sugar (Hiles, 1947) . Although most authors accept the threshold hypothesis, there have been suggestions 'that the vagal stimulation resulted more from a rapid decline in blood sugar than from its actual value at any one time' (Hiles, 1947) , or that 'a falling blood sugar may be sufficient for stimulation regardless of the rate or depth of that fall' (Stempien et al, 1968) . However, the results in diabetic humans (Kalk and Meyer, 1932) 
It seems reasonable to conclude from these studies that when the blood glucose falls, acid secretion is initiated at a certain threshold, and that a fall of blood glucose which does not reach this threshold, however rapid and even if the value is as large as several hundred mg/100 ml, will not initiate gastric secretion. Although there does not seem to be any universal threshold for blood sugar in man or dog, the human threshold appears to be between 33 and 73 mg/lOOml (Demand et al, 1968 ), but may not be the same in the same individual from day to day. This threshold is below the range of blood glucose during normal activities, and there was no correlation between basal acid output and blood glucose in the present series. It is, therefore, unlikely that variations in spontaneous interdigestive basal secretion in man could be due to variations in blood sugar.
INSULIN DOSE, HYPOGLYCAEMIA, AND ACID OUTPUT
The results presented have shown a quantitative relationship between insulin hypoglycaemia and gastric acid output. This relationship has not previously been described, and the literature has therefore been reviewed critically to explain these differences. (Fig. 6) ; there is a significant inverse linear correlation of gastric acid output with the lowest blood sugar concentration, similar to the results in the present paper (Fig. 2a) . Similarly, recalculation of the data of Metys and Ronsky (1959) suggests an inverse linear correlation (similar to Figs. 2a and 6) of acid output with the lowest blood sugar concentration (n = 6, r = -0.69, p = 0.066).
The most recent and apparently definitive studies of insulin hypoglycaemia in the dog Brooks, 1962 and Davis, Brooks, and Robert, 1965; Brooks, 1967) claimed that the authors had confirmed the old 'all-or-none' law, although they failed to consider that acid response after single parenteral injections of drugs in man or dog should be analysed in terms of peak acid output (Marks, Komarov, and Shay, 1960;  Baron, 1962 and Makhlouf, 1968) irrespective of the timing of peak acid output (Baron, 1968 and 1969 Intravenously Similar acidities after each of 'All-or-none ' Bachrach and Bachrach (1967) group.bmj.com on June 24, 2017 -Published by http://gut.bmj.com/ Downloaded from initiated after insulin hypoglycaemia is a quantitative vagal acid response in response to a quantitative glycopenic stimulus. It seems clear that previous reports, which have almost consistently claimed an 'all-or-none' response, have been almost exclusively based on studies of different subjects or animals. In the few studies where the same animal has been studied on more than one eccasion, recalculation of the data produced complete agreement with the interpretation of the human data of the present study.
The graphs of the correlation of acid output with lowest blood sugar (Figs. 2 and 6) are mirrored by the dose-response curves of peakacid output and insulin dose (Fig. 5a) . However, the scatter of points along the line in Fig. 5 is considerable, presumably because the reproducibility of the insulin test is poorer than for other gastric near-maximal stimuli. For example, the coefficient of variation of 25 duplicate measurements of peak acid output after 0.15 units/kg insulin was 16 % (Hubel, 1966) as compared with 8 % after an augmented histamine test (Baron, 1963) , or 9% after pentagastrin (Baron, 1969) . The imprecision of this relationship of acid output and insulin dose is understandable if 'the dose of insulin required to produce a given degree of hypoglycaemia cannot be predicted, because it varies not only in different individuals (man or animal) but also in the same individual from day to day' (Bachrach, 1953) .
INHIBITION OF GASTRIC SECRETION AFTER INSULIN
In the present study there was no significant inhibition in the first half hour after insulin, but acid output was apparently increasingly inhibited at extreme hypoglycaemia, below about 15 mg/100 ml. The literature on this problem is most confusing, because inhibition has been reported both soon and late after insulin, because different commercial insulins contain different amounts of glucagon, and because the inhibition after insulin may not be due to the hypoglycaemia but may be related to some other change in the internal environment of the cephalic centres or the parietal cells of the stomach. Animal data Morris (1940 and 1941) noticed depression of gastric motility and tone after 0-5-0.7 u/kg Squibb insulin in the dog; this inhibition coincided with very low blood sugars (10-28 mg/100 ml), and, as the blood sugar rose to medium and slightly subnormal values, the typical insulin hypermotility appeared. Necheles, Olson, and Scruggs (1942) showed that mild hypoglycaemia from low doses of insulin stimulated gastric secretion from Pavlov pouches; severe hypoglycaemia from higher doses of insulin produced less stimulation; other similar results have been summarized in Table IV . The simplest explanation for the inhibition of gastric secretion associated with hypoglycaemia was that the low blood glucose directly inhibits parietal cell function as does anoxia (Pickett and van Liere, 1939) analogous to the depression of intestinal enzyme output (Kneller and Nasset, 1949) or colonic motility (Killenberg and Cornwell, 1964 ) associated with severe hypoglycaemia. Indeed, Jordan and Quintana (1964) were able to inhibit insulin-stimulated gastric secretion by inducing profound hypoglycaemia with a larger dose of insulin; both this hypoglycaemia and the inhibition were still produced if glucagon-free insulin was used, and both were prevented by glucose infusions. Eisenberg, Woodward, Quintana, and Dragstedt (1963) could not prevent insulin inhibition of histamine-stimulated acid by glucose infusion, and therefore suggested that'a transient hyperkalosis of the parietal cell temporarily interferes with acid elaboration . . .'.
Hirschowitz and his co-workers (Hirschowitz and O'Leary, 1964; Hirschowitz, 1966; Hirschowitz and Sachs, 1967a and b) have systematically studied the inhibitory action on histaminestimulated secretion of large dosesof insulin. This inhibition was obtainedwithglucagon-free insulin, was dose-dependent, associated with a fall in plasma and gastric juice potassium, and not reversed by prevention or correction of the hypoglycaemia, but was reversed or prevented by intravenous potassium chloride or by intravenous rubidium. The inhibition associated with very high doses of insulin in the rat (Lee and Thompson, 1967) and dog (Kemp, Herrera, Tsukamoto, and Eisenberg, 1968b) coincided with depression of blood sugar and serum potassium.
It seems clear from these studies that insulin could both (vagally) stimulate and (peripherally) inhibit gastric secretion. There are two possible experimental methods of confirming this double action of insulin by studying the two effects independently.
First, ruminants (who have no psychic vagal phase of gastric secretion) show only inhibition of gastric acid after insulin with a significant correlation between blood sugar and titratable acidity. This inhibition was unaffected by -vagotomy and was therefore a peripheral effect associated with hypoglycaemia (Hitchcock, 835 Dose response relationships of insulin hypoglycaemia and gastric acid in man Karvonen, andPhillipson, 1948) . Secondly, a nonhypoglycaemic drug such as 2-D-deoxy-glucose could be used as a vagal stimulant; increasing doses showed no dose-response reversal, and the peak acid output after 2-D-deoxy-glucose was significantly higher than after insulin (Hirschowitz and Sachs, 1965; Eisenberg et al, 1966 Roholm (1930) after Leo insulin. Olson and Necheles (1953) therefore systematically studied in 15 patients with duodenal ulcer the change in acid after 25 units insulin and found a significant decrease at 30 minutes compared with pre-insulin acid output. A similar significant reduction was found in the volume, acidity, and acid output at 15 and 30 minutes after regular insulin in 33 healthy subjects (Olsen and Necheles, 1955) and it was thought possible that this inhibition could be due to the glucagon in this insulin. Aylett (1963) has reviewed the effect ofglucagon on gastric secretion in man and animal, having shown (Aylett, 1962) that as little as 2 mg glucagon intravenously would significantly inhibit gastric secretion in response to a water meal and that inhibition was present even iftheglucagonwas given at the same time as glucagon-free insulin. Aylett agreed that the biphasic action of 'insulin' .upon gastric secretion may have been due to the glucagon contamination, and she suggested that 'glucagon-free insulin' should always be used for this test.
The glucagon content of commerical insulin varies considerably, wasprobablyalways considerable from the 1920s to the 1940s, and may have been responsible for the many previous reports of an early phase of inhibition of gastric secretion after 'insulin'. However, in thelast twentyyearsthe manufacturing methods in Britain and Denmark have changed, and these insulins, unlike some American insulins (Rowlinson and Lesford,1951) , now contain insignificant amounts of hyperglycaemic factor. In the present studies no significant early inhibitory phase was noted after the Boots insulin, which with other British insulins, as well as Novo insulin, have glucagon concentrations so low (less than 0-01 %) as to be negligible, and therefore are suitable for the insulin test, as is Lilly crystalline insulin (0.1 % glucagon).
EXTREME HYPOGLYCAEMIA IN MAN
In one patient in the series of Clark et al (1964) a fall in blood glucose of more than 60 mg/100 ml (fasting and lowest blood glucose not stated) was associated with relatively low peak acid output after insulin compared with post-histamine acid output.
There are no other reports in the literature of extreme hypoglycaemia being achieved in man in an insulin test, but the results of the present study in which blood glucose concentrations below 15 mg/100 ml were associated with decreased acid output are entirely compatible with the results in animals subject to extreme hypoglycaemia, irrespective of whether the mechanism of inhibition of parietal cell function is by decrease in the glucose concentration and/or the potassium concentration in the brood.
CRITERIA FOR AN ADEQUATE INSULIN TEST IN THE UNOPERATED SUBJECT
Obviously, the results in one individual may not be taken as representative and further tests with different doses of insulin are needed in many different subjects. However, the present results suggest that an insulin dose of about 0.2 u/kg may be optimum in producing sufficient hypoglycaemia (blood glucose below 30 mg/100 ml) to guarantee initiation of gastric secretion in an individual, to ensure a near maximum vagal acid output, and to prevent blood glucose falling so low (below 15 mg/100 ml) that hypoglycaemic inhibition of gastric secretions or dangerous side effects are produced. Addendum Isenberg, Stening, Ward, and Grossman (1969) gave intravenous injections of insulin (0.025-0.4 u/kg) to five healthy men. Peak 15-minute acid output was similar after 0-1, 0.2 and 0.4 u/kg and highest after 0.2 u/kg. Blood glucoses at 30 minutes were similar after 0.1-0.4 u/kg, but no acid/ glucose correlations were made. Stening and Isenberg (1969) 
